INDIANAPOLIS – (October 1, 2024) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and an Operating Company of Danaher Corporation (NYSE: DHR), announces the ...

Fidelity, Scalable, Non-Toxic On-Premises Biofoundry CapabilitiesSAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader ...

SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create ...

Beckman Coulter Diagnostics, a leader in clinical diagnostics, and Scopio Labs, a medtech company specialising in digital ...

Shares of Telesis Bio, Inc. TBIO rose sharply in today's pre-market trading session after the company announced a partnership ...

Shares of Telesis Bio were trading at double their closing price in the after-hours market following news the company entered a collaboration deal with Beckman Coulter Life Sciences.

BREA, Calif. and TEL AVIV, Israel, Sept. 17, 2024 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow ...

Telesis Bio and Beckman Coulter Life Sciences announced an new partnership on Thursday. The companies aim to revolutionize DNA and mRNA synthesis by creating efficient and scalable biofoundries.

Shares of Telesis Bio (NASDAQ:TBIO) surged ~110% in the premarket on Thursday after the nano-cap life sciences company ...